BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9894899)

  • 1. Construction of a specific and sensitive sandwich enzyme immunoassay for 20 kDa human growth hormone.
    Hashimoto Y; Ikeda I; Ikeda M; Takahashi Y; Hosaka M; Uchida H; Kono N; Fukui H; Makino T; Honjo M
    J Immunol Methods; 1998 Dec; 221(1-2):77-85. PubMed ID: 9894899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific monoclonal antibodies and ultrasensitive immunoassays for 20K and 22K human growth hormone.
    Wu Z; Devany E; Balarini G; Junnila R; Bidlingmaier M; Strasburger CJ
    Growth Horm IGF Res; 2010 Jun; 20(3):239-44. PubMed ID: 20304691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 22 kDa human growth hormone specific enzyme-linked immunosorbent assay.
    Yuki Y; Kato K
    Biol Pharm Bull; 1994 Jul; 17(7):977-9. PubMed ID: 8000389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentration of 20K human growth hormone (20K hGH) measured by a specific enzyme-linked immunosorbent assay. Study Group of 20K hGH.
    Tsushima T; Katoh Y; Miyachi Y; Chihara K; Teramoto A; Irie M; Hashimoto Y
    J Clin Endocrinol Metab; 1999 Jan; 84(1):317-22. PubMed ID: 9920101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of a SPR immunosensor for the simultaneous detection of the 22K and 20K hGH isoforms in human serum samples.
    de Juan-Franco E; Rodríguez-Frade JM; Mellado M; Lechuga LM
    Talanta; 2013 Sep; 114():268-75. PubMed ID: 23953470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of monoclonal antibodies specific for the human growth hormone 22K and 20K isoforms.
    Mellado M; Rodriguez-Frade JM; Kremer L; Martinez-Alonso C
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1613-8. PubMed ID: 8636376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous 20K growth hormone (GH) suppresses endogenous 22K GH secretion in normal men.
    Hashimoto Y; Kamioka T; Hosaka M; Mabuchi K; Mizuchi A; Shimazaki Y; Tsunoo M; Tanaka T
    J Clin Endocrinol Metab; 2000 Feb; 85(2):601-6. PubMed ID: 10690862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the effect on the human prolactin receptor.
    Tsunekawa B; Wada M; Ikeda M; Uchida H; Naito N; Honjo M
    Endocrinology; 1999 Sep; 140(9):3909-18. PubMed ID: 10465259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale preparation and in vitro characterization of biologically active human placental (20 and 22K) and pituitary (20K) growth hormones: placental growth hormones have no lactogenic activity in humans.
    Solomon G; Reicher S; Gussakovsky EE; Jomain JB; Gertler A
    Growth Horm IGF Res; 2006; 16(5-6):297-307. PubMed ID: 17010651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of 20K human growth hormone in normal adults and patients with various endocrine disorders. Study Group of 20K hGH.
    Tsushima T; Katoh Y; Miyachi Y; Chihara K; Teramoto A; Irie M; Hashimoto Y
    Endocr J; 2000 Mar; 47 Suppl():S17-21. PubMed ID: 10890176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 20 kDa human growth hormone (20K hGH) stimulates insulin-like growth factor-I (IGF-I) gene expression at lower concentrations than 22K hGH in hGH receptor-expressing Ba/F3 cells.
    Yoshizato H; Tanaka M; Fujikawa T; Higashimoto Y; Shimizu A; Nakashima K
    Endocr J; 2000 Mar; 47 Suppl():S37-40. PubMed ID: 10890180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the complex formation with cell surface hGH receptor and hGH-binding protein circulating in human plasma.
    Wada M; Uchida H; Ikeda M; Tsunekawa B; Naito N; Banba S; Tanaka E; Hashimoto Y; Honjo M
    Mol Endocrinol; 1998 Jan; 12(1):146-56. PubMed ID: 9440818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-kilodalton human growth hormone (20K hGH) secretion from growth hormone-secreting pituitary adenoma cells in vitro.
    Murakami Y; Mori T; Koshimura K; Kurosaki M; Takenobu A; Hashimoto Y; Kato Y
    Endocr J; 2000 Oct; 47(5):563-8. PubMed ID: 11200936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding between the stem regions of human growth hormone (GH) receptor compensates for the weaker site 1 binding of 20-kDa human GH (hGH) than that of 22-kDa hGH.
    Tsunekawa B; Wada M; Ikeda M; Banba S; Kamachi H; Tanaka E; Honjo M
    J Biol Chem; 2000 May; 275(21):15652-6. PubMed ID: 10748003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetogenic activity of 20 kDa human growth hormone (20K-hGH) and 22K-hGH in rats.
    Takahashi S; Shiga Y; Satozawa N; Hayakawa M
    Growth Horm IGF Res; 2001 Apr; 11(2):110-6. PubMed ID: 11472077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 20K is bound with high affinity by one rat and one of two rabbit growth hormone receptors.
    Hughes JP; Tokuhiro E; Simpson JS; Friesen HG
    Endocrinology; 1983 Nov; 113(5):1904-6. PubMed ID: 6313333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular activities of 20K- and 22K-hGH do not necessarily correlate with their binding affinities for rat GH receptor.
    Ikeda M; Matsumoto K; Uchida H; Naito N; Tsunekawa B; Wada M; Honjo M
    Horm Res; 2000; 54(3):136-42. PubMed ID: 11357007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant deoxyribonucleic acid-derived 22K- and 20K-human growth hormone generate equivalent diabetogenic effects during chronic infusion in dogs.
    Ader M; Agajanian T; Finegood DT; Bergman RN
    Endocrinology; 1987 Feb; 120(2):725-31. PubMed ID: 3542508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly sensitive radioimmunoassay for human growth hormone using a monoclonal antibody.
    Gomez F; Pirens G; Schaus C; Closset J; Hennen G
    J Immunoassay; 1984; 5(3-4):145-57. PubMed ID: 6530481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acute effects of growth hormone on amino acid transport and protein synthesis are due to its insulin-like action.
    Cameron CM; Kostyo JL; Adamafio NA; Brostedt P; Roos P; Skottner A; Forsman A; Fryklund L; Skoog B
    Endocrinology; 1988 Feb; 122(2):471-4. PubMed ID: 3276499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.